Abstract
To look at the occurrence of ipecac misuse in two high-risk populations, we distributed a structured self-report questionnaire regarding eating attitudes and behaviors to a non-clinical sample of 5,537 young women in a national collegiate social organization and to a clinical sample of 299 consecutive outpatients referred to our Eating Disorders Clinic. The lifetime prevalence of ipecac use in the college population was 2.5% compared to 10% in the outpatient sample. The prevalence rates in both populations suggest that further restriction of syrup of ipecac by warnings of toxicity on labels, package inserts, and pharmacist dispension over-the-counter should be considered
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
